Dyax, taiba ME partner on angiodema treatment

Dyax Corp. (NASDAQ: DYAX) of Burlington said today that it has given exclusive distribution rights to taiba ME to use Dyax’s Kalbitor to treat hereditary angioedema in the Middle East.